Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2021-08-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/8/e002568corr1.full
id doaj-f5c599caed494d1c952b0ee414c07992
record_format Article
spelling doaj-f5c599caed494d1c952b0ee414c079922021-08-12T14:00:03ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-08-019810.1136/jitc-2021-002568corr1Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trialhttps://jitc.bmj.com/content/9/8/e002568corr1.full
collection DOAJ
language English
format Article
sources DOAJ
title Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
spellingShingle Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Journal for ImmunoTherapy of Cancer
title_short Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
title_full Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
title_fullStr Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
title_full_unstemmed Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
title_sort correction: neoadjuvant nivolumab for patients with resectable hpv-positive and hpv-negative squamous cell carcinomas of the head and neck in the checkmate 358 trial
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2021-08-01
url https://jitc.bmj.com/content/9/8/e002568corr1.full
_version_ 1721209477366022144

Similar Items